[Editor’s note: This piece originally appeared as a letter to the editor in response to “Medicaid and Transgender Treatments for Kids,” published Aug. 18 in the Wall Street Journal.]
Your editorial “Medicaid and Transgender Treatments for Kids” (Aug. 18) correctly notes that public funding will continue to support the mental-health needs of children with gender dysphoria after the Trump administration’s recent rule change for Medicaid and the Children’s Health Insurance Program. Funds through those programs simply can no longer go to puberty blockers, hormone therapies or gender surgeries for minors. This is good news. Let’s hope that in general mental-health services stop perpetuating the “affirmative” model of care that has already led so many children to use these irreversible, invasive medical practices.
Read the full piece in the Wall Street Journal.
